SACHRP: FDA Should Revise Informed Consent Waivers to Match HHS Rules

The Secretary’s Advisory Committee on Human Research Protections is recommending the FDA revise its informed consent waivers for cluster randomized trials to mirror HHS rules.
Source: Clinical Trials Advisor